Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Trial ID or NCT#
NCT00377949
Status
RECRUITING
Purpose
The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disease as defined as death, hospitalization, or worsening of PHT symptoms.
Official Title
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Eligibility Criteria
Ages Eligible for Study: 18 Years to 75 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Contact us to find out if this trial is right for you.
Contact
Jennifer Hughes
View on ClinicalTrials.gov
